论文部分内容阅读
目的探讨地屈孕酮治疗早期先兆流产的临床疗效。方法选取2012年1月至2013年1月妇产科治疗的早期先兆流产的患者120例,随机均分为对照组和观察组各60例。对照组采用黄体酮治疗;观察组采用地屈孕酮治疗。结果对照组保胎成功率83.33%;观察组86.367%,两组比较差异无统计学意义,P>0.05。结论在黄体功能不全所致的先兆流产治疗中,地屈孕酮与黄体酮相比,临床疗效差异无统计学意义。且地屈孕酮为口服药,治疗方便,患者耐受性好,可以广泛应用于先兆流产的保胎治疗。
Objective To investigate the clinical efficacy of dydrogesterone in the treatment of early threatened abortion. Methods 120 patients with early threatened abortion underwent obstetrics and gynecology from January 2012 to January 2013 were randomly divided into control group and observation group of 60 cases. The control group was treated with progesterone; the observation group was treated with dydrogesterone. Results In the control group, the success rate of miscarriage was 83.33% and that of the observation group was 86.367%. There was no significant difference between the two groups (P> 0.05). Conclusions In the treatment of threatened abortion caused by corpus luteum insufficiency, there is no significant difference in clinical efficacy between dydrogesterone and progesterone. And to bend progesterone oral medication, easy treatment, patients with good tolerance, can be widely used in threatened abortion miscarriage treatment.